(Oslo, Norway, 14 October 2014) Bionor Pharma ASA Deputy Chairman Øystein Soug’s directly owned company Abakus Invest AS has on 13 October bought 79 545 shares in Bionor Pharma from Øystein Soug at NOK 2,38.Abakus Invest AS holds 107,205 shares after the transaction.
Q3 2014 financial results presentation will be held Tuesday 4 November at 08.30.Read more about Q3 Presentation
Find latest company presentations and quarterly report.Read more about Company Presentation
Capital Markets Day 14 June 2013: Bionor Pharma presents the new clinical strategy towards a potential cure for HIV.Read more about Video: Capital Markets Day
The therapeutic vaccine candidate Vacc-4x has shown significant reduction of HIV virus in a phase II randomized, multinational, double-blind, placebo-controlled study.Read more about Leading T-cell Vaccine